BiomeBank Submits for Market Authorisation of World First Microbial Therapy

ADELAIDE, South Australia--(BUSINESS WIRE) The company behind Australia’s first facility for the manufacturing of microbial therapies has set its sights on global impact, applying to the Therapeutic Goods Administration, Australia’s regulatory authority, for approval of their world-first biologic drug product. “In addition to our existing syringe-based therapy, we are also developing capsule based-products that will…

0 Comments

Faecal transplants to help treat symptoms of Parkinson’s

Media Release Revolutionary faecal transplants are the latest new treatment option being trialled in people living with Parkinson’s to help manage their debilitating symptoms by replenishing their healthy gut bacteria. The trial is the result of an exciting collaboration between leading Australian biotechnology company BiomeBank, the Departments of Neurology, Nuclear Medicine and Gastroenterology within the Royal…

0 Comments